200 related articles for article (PubMed ID: 19067241)
1. Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris.
Miltenyi Z; Toth J; Gonda A; Tar I; Remenyik E; Illes A
Pathol Oncol Res; 2009 Sep; 15(3):375-81. PubMed ID: 19067241
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour.
Wolff H; Kunte C; Messer G; Rappersberger K; Held E; Löhrs U; Plewig G; Meurer M
Br J Dermatol; 1999 Feb; 140(2):313-6. PubMed ID: 10233229
[TBL] [Abstract][Full Text] [Related]
3. [Paraneoplastic pemphigus revealing dendritic cell sarcoma originating from Castleman's disease of the neck].
Gironet N; De Muret A; Machet L; Diot P; Rivollier C; Dumont P; Lorette G; Vaillant L
Ann Dermatol Venereol; 2005 Jan; 132(1):41-4. PubMed ID: 15746607
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides-like eruption. A case report and review of literature.
Hsiao CJ; Hsu MM; Lee JY; Chen WC; Hsieh WC
Br J Dermatol; 2001 Feb; 144(2):372-6. PubMed ID: 11251576
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic pemphigus caused by pre-existing stroma-rich variant of Castleman disease: from a pathologist's point of view.
Gwiti P; Melegh Z; Johnston S; Sutak J
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33975839
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.
Chorzelski T; Hashimoto T; Maciejewska B; Amagai M; Anhalt GJ; Jablonska S
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):393-400. PubMed ID: 10459112
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic pemphigus: Retrospective study of a case series].
Fournet M; Roblot P; P Levillain ; Guillet G; Machet L; Misery L
Ann Dermatol Venereol; 2018 Oct; 145(10):564-571. PubMed ID: 30126641
[TBL] [Abstract][Full Text] [Related]
8. Castleman disease and paraneoplastic pemphigus in a pregnant woman: A case report.
Cui B; Lin H
Medicine (Baltimore); 2021 Apr; 100(13):e24990. PubMed ID: 33787583
[TBL] [Abstract][Full Text] [Related]
9. Clinical images: Castleman disease and paraneoplastic pemphigus.
Kop EN; MacKenzie MA
CMAJ; 2010 Jan; 182(1):61. PubMed ID: 19884299
[No Abstract] [Full Text] [Related]
10. Paraneoplastic Pemphigus Associated With Castleman Disease Detected by 18F-FDG PET/CT.
Fu Z; Liu M; Chen X; Yang X; Li Q
Clin Nucl Med; 2018 Jun; 43(6):464-465. PubMed ID: 29561527
[TBL] [Abstract][Full Text] [Related]
11. [A case of retroperitoneal Castleman's disease with paraneoplastic pemphigus].
Zhang Z; Zhou M; Guo J; Feng T; Li X; Chen H; Li J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 May; 41(5):548-52. PubMed ID: 27269932
[TBL] [Abstract][Full Text] [Related]
12. Follicular dendritic cell sarcoma aggravated by hyaline-vascular Castleman's disease in association with paraneoplastic pemphigus: study of the tumor and successful treatment.
Wang J; Wang X; Xu J; Song P
An Bras Dermatol; 2019; 94(5):578-581. PubMed ID: 31777359
[TBL] [Abstract][Full Text] [Related]
13. Successful use of intravenous and intralesional rituximab in paraneoplastic pemphigus with Castleman's disease.
Viswanath V; Tare D; Patil PC
Int J Dermatol; 2021 Sep; 60(9):e352-e354. PubMed ID: 33720390
[No Abstract] [Full Text] [Related]
14. Paraneoplastic Pemphigus. A Life-Threatening Autoimmune Blistering Disease.
Tirado-Sánchez A; Bonifaz A
Actas Dermosifiliogr; 2017 Dec; 108(10):902-910. PubMed ID: 28801011
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China.
Wang J; Zhu X; Li R; Tu P; Wang R; Zhang L; Li T; Chen X; Wang A; Yang S; Wu Y; Yang H; Ji S
Arch Dermatol; 2005 Oct; 141(10):1285-93. PubMed ID: 16230567
[TBL] [Abstract][Full Text] [Related]
16. Retroperitoneal Castlemans disease associated with paraneoplastic pemphigus.
Choh NA; Qayoom S; Shaheen F; Malik RA; Rabbani I; Gojwari T
Hematol Oncol Stem Cell Ther; 2014 Jun; 7(2):93-6. PubMed ID: 24333134
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic Pemphigus.
Gu L; Ye S
J Clin Rheumatol; 2019 Aug; 25(5):e77-e78. PubMed ID: 29389687
[No Abstract] [Full Text] [Related]
18. Paraneoplastic pemphigus: a refractory autoimmune mucocutaneous disease.
Ng PP; Rencic A; Nousari HC
J Cutan Med Surg; 2002; 6(5):434-7. PubMed ID: 12196890
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide as a potential adjuvant treatment for paraneoplastic pemphigus: A single-center experience.
Wang J; Zhang Y; Pan M
Dermatol Ther; 2020 Nov; 33(6):e14353. PubMed ID: 32990359
[TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal reticulum cell sarcoma: a cause of paraneoplastic pemphigus.
Berg WA; Fishman EK; Anhalt GJ
South Med J; 1993 Feb; 86(2):215-7. PubMed ID: 8434295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
